Divergent Effects of Chronic HIV-1 Infection on Human Thymocyte Maturation in SCID-hu Mice
Overview
Authors
Affiliations
We have recently developed a modified SCID-hu mouse model in which the implanted human thymus and liver (hu-thy/liv) and human peripheral T cells become infected with HIV-1 after i.p. inoculation. By using this model, we evaluated the effect of HIV-1 infection on thymic maturation and observed that different HIV-1 strains had divergent effects of thymic maturation. Although minimal effects on continued thymopoiesis in the hu-thy/liv implant were observed after chronic infection with two primary patient isolates, HIV-1(28) and HIV-1(59), and with HIV-1ADA, HIV-1Ba-L, HIV-1JR-CSF, HIV-1JR-FL, and HIV-1SF162, significant thymocyte depletion was detected after infection with HIV-1IIIB and HIV-1RF. Thus, the effect of HIV-1 infection on thymocyte maturation may depend upon the strain of HIV-1 infecting the thymus. Despite the minimal effects on thymopoiesis observed in the hu-thy/liv implanted in SCID-hu mice 6 mo after infection with HIV-1(28), significant changes were seen in the human T cell population circulating in the peripheral blood of these mice. These changes ranged from an inversion of the CD4/CD8 ratio of peripheral human T cells in some SCID-hu mice to the almost complete depletion of peripheral human T cells observed in other SCID-hu mice. Because these effects were associated with the detection of HIV-1 infection of the peripheral human T cells, these modified SCID-hu mice should prove to be a valuable model for investigating the effects of chronic HIV-1 infection on the peripheral human T cell population.
Evans V, Lal L, Akkina R, Solomon A, Wright E, Lewin S Retrovirology. 2011; 8:43.
PMID: 21639903 PMC: 3118182. DOI: 10.1186/1742-4690-8-43.
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.
Dadachova E, Patel M, Toussi S, Apostolidis C, Morgenstern A, Brechbiel M PLoS Med. 2006; 3(11):e427.
PMID: 17090209 PMC: 1630718. DOI: 10.1371/journal.pmed.0030427.
Sempowski G, Hicks C, Eron J, Bartlett J, Hale L, Ferrari G J Clin Immunol. 2005; 25(5):462-72.
PMID: 16160915 DOI: 10.1007/s10875-005-5635-4.
Koka P, Kitchen C, Reddy S J Virol. 2004; 78(20):11385-92.
PMID: 15452260 PMC: 521839. DOI: 10.1128/JVI.78.20.11385-11392.2004.
Ruiz-Mateos E, Rubio A, Vallejo A, De la Rosa R, Sanchez-Quijano A, Lissen E Clin Exp Immunol. 2004; 136(3):501-6.
PMID: 15147352 PMC: 1809045. DOI: 10.1111/j.1365-2249.2004.02474.x.